| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |